Delivery Order SPE2DR25D9762-SPE2DR26FHZC8
Award Date 2/4/26
Potential Completion Date 2/4/26
Potential Value $2.5K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $4,764.20 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical supply. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical...
- The Defense Logistics Agency issued a $65,779.20 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 4, 2026, with a ceiling value of $21,573 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency issued a $17,688.64 delivery order to DMS Pharmaceutical Group Inc. on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products supporting Department of Defense medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 4, 2026, with a ceiling value of $85,700.12 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic prescription drugs,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, with a ceiling value of $2,492.64 for pharmaceutical products under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order is issued under the single-award Indefinite Delivery Contract SPE2DR, awarded...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, with a ceiling value of $3,167.01 for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V indefinite delivery contract (contract SPE2DR, awarded November 13, 2025, with a $499.999 billion ceiling and completion date of December 31,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 5, 2026, with a ceiling value of $3,691.14 for pharmaceutical products. This delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award Indefinite Delivery Contract with a $499,999,999 ceiling that authorizes DLA to procure branded and generic prescription...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, with a ceiling value of $4,154.40 for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for branded...
- The Defense Logistics Agency awarded a $7,384.63 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on January 12, 2026, with completion targeted for January 14, 2026, represents one of numerous orders placed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
- SPE2DR25D9762Indefinite Delivery Contract
- SPE2DR25D9762-SPE2DR26FHZC8Delivery Order
The Defense Logistics Agency issued a $2,494.80 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. The order is firm fixed price with place of performance in Park Ridge, IL. DMS Pharmaceutical Group holds a single-award IDC under PPV-G GEN V with a $499,999,999 ceiling and ultimate completion date of December 31, 2036.
Generated 5/6/26, 12:51 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 2/3/26 |